Φορτώνει......
Advanced non-small cell lung cancer: the role of PD-L1 inhibitors
PD-L1 and PD-1 inhibitors were both developed to combat a huge array of cancers. Both classes of agents block the PD-1/PD-L1 pathway. Unlike PD-1 inhibitors, PD-L1 inhibitors do also block the B-7.1-receptor and leave the PD-L2/PD-1 axis unaffected. Whether these differences enhance efficacy and tol...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Thorac Dis |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
AME Publishing Company
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994502/ https://ncbi.nlm.nih.gov/pubmed/29951298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.01.112 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|